World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 5 September 2016
Main ID:  NCT02872818
Date of registration: 16/08/2016
Prospective Registration: No
Primary sponsor: Kayseri Education and Research Hospital
Public title: Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
Scientific title: The Effect of Metformin and Medroxyprogesterone Acetate on Apoptotic Signaling Pathways in Wistar-Albino Rats With Induced Endometrial Hyperplasia
Date of first enrolment: October 2014
Target sample size: 40
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02872818
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Turkey
Contacts
Name:     Erdem SAHIN
Address: 
Telephone:
Email:
Affiliation:  Kayseri Training and Research Hospital
Key inclusion & exclusion criteria

Inclusion criteria:

Forty-eight weeks old female Wistar-Albino rats, weighting between 180 and 260 g

Exclusion criteria.

We have no exclusion criteria because we examine drugs effects in the experimental rats



Age minimum: 8 Weeks
Age maximum: 10 Weeks
Gender: Female
Health Condition(s) or Problem(s) studied
Apoptotic Signal Pathways in Endometrial Hyperplasia
Intervention(s)
Drug: 17ß estradiol hemihydrate
Drug: medroxyprogesterone acetate
Drug: Metformin
Primary Outcome(s)
Bax Gene Expression Levels in Rat Uterine Tissue [Time Frame: 4 months]
Bcl-2 Gene Expression Levels in Rat Uterine Tissue [Time Frame: 4 months]
c-Myc Gene Expression Levels in Rat Uterine Tissue [Time Frame: 4 months]
Caspase-9 Expression Levels in Rat Uterine Tissue [Time Frame: 4 months]
Survivin Gene Expression Levels in Rat Uterine Tissue [Time Frame: 4 months]
Secondary Outcome(s)
Secondary ID(s)
14/128
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history